PATENT CLAIM ANALYSIS

Application Number: 16069699
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "367000"]

Abstract:
The present invention relates to a temporary inhibitor of p53 for its use for preventing or reducing cancer relapse in cancer patients.

Claim (Index 9):
The method according to  claim 2 , wherein the anticancer agent is a platinum anticancer drug.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 95.0
- Lexical Diversity: 1.09524
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09880417', '10350560', '11433079', '13772944', '15320089']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7690740220371456
- 35 USC 102 Novelty (BERT): 0.5195527753909256
- Combined Prediction Score: 0.7441218973725237
- Mean Citation Score: 245.295178
- Max Citation Score: 256.48914
- Similarity Product: 141.09926961097602

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test